Dr Zag Ambwani (India) Llp
About Dr Zag Ambwani (India) Llp
Data last updated: 05 March 2026
Dr Zag Ambwani (India) Llp is a limited liability partnership company based in Ahmedabad, Gujarat, India. It specialises in industrial chemicals, a part of the broader chemicals and materials sector. Incorporated on 19 February 2020, the LLP has been in operation for over 6 years.
Registered with ROC Ahmedabad under LLPIN AAR-9790.
Capital: a total obligation of contribution of ₹41 Lakh. It is led by designated partners including Nilesh Carpenter and Sarla Jaikishan Ambwani.
Accounts filed on 31 March 2025. Office: B 120 Kubernagar, Ahmedabad, Gujarat, India – 382340.
The LLP is associated with 1 brand — Maitri Enterprises. As per MCA filings, the LLP has open charges of ₹1.3 Cr on record.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressB 120 Kubernagar, Ahmedabad, Gujarat, India – 382340
-
IndustryChemicals and Materials, Industrial Chemicals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Dr Zag Ambwani (India) Llp
Dr Zag Ambwani (India) Llp operates one associated brand: Maitri Enterprises. These brands represent Dr Zag Ambwani (India) Llp's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products and medical devices are distributed in India. | maitrienterprises.com |
Competitors & Alternatives of Dr Zag Ambwani (India) Llp
Brands and companies operating in the same space as Dr Zag Ambwani (India) Llp include Entero Healthcare, AmerisourceBergen, Keimed and 3 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
India's leading healthcare products distribution platform | Mumbai, India, India | 2018 |
|
|
Pharmaceutical distribution and supply chain services are provided globally. | Chesterbrook, United States, United States | 1985 |
|
|
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | Hyderabad, India, India | 2000 |
|
|
Provider of medical equipment, devices, and drugs distribution services | Hyderabad, India, India | 1995 |
|
|
Distributor of pharmaceutical raw materials | Ahmedabad, India, India | 2011 |
|
|
Serves as a distributor of a wide range of pharmaceutical drugs. | Bengaluru, India, India | 2016 |
Designated Partners of Dr Zag Ambwani (India) Llp
Dr Zag Ambwani (India) Llp is currently managed by 4 designated partners, with 1 former designated partner having served the organization. The current Designated Partners play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nilesh Carpenter | Designated Partner | 19 Feb 2020 | 6 Years 4 Months | Current |
|
Sarla Jaikishan Ambwani
Also directs:
Bsa Infrabuild Llp, Gayatri Infrastructure Limited, Satyabhamadevi Bulchand Memorial Hospital Private Limited and 3 more
|
Designated Partner | 19 Feb 2020 | 6 Years 4 Months | Current |
|
Jaikishan Rameshlal Ambwani
Also directs:
Bulsons Corporation Llp, Bsa Infrabuild Llp, Gayatri Infrastructure Limited and 5 more
|
Designated Partner | 25 Jun 2020 | 6 Years 0 Months | Current |
| Chanderlal Ambwani Bulchand | Designated Partner | 19 Feb 2020 | 6 Years 4 Months | Current |
Financials of Dr Zag Ambwani (India) Llp FY 2025 filings available
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Charges & Borrowings of Dr Zag Ambwani (India) Llp
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Feb 2022 | Bank of India | ₹40 Lakh | Open |
| 01 Feb 2022 | Bank of India | ₹90 Lakh | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Dr Zag Ambwani (India) Llp
View historical data on people associated with Dr Zag Ambwani (India) Llp, including employment history and EPFO contributions.
Employee Count & EPFO Data of Dr Zag Ambwani (India) Llp
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Dr Zag Ambwani (India) Llp
GSTIN & GST Filing Data of Dr Zag Ambwani (India) Llp
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Dr Zag Ambwani (India) Llp
Credit Ratings, Legal Cases & Regulatory Alerts of Dr Zag Ambwani (India) Llp
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Dr Zag Ambwani (India) Llp
MSME Payment Delays by Dr Zag Ambwani (India) Llp
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Dr Zag Ambwani (India) Llp
Subsidiaries & Group Companies of Dr Zag Ambwani (India) Llp
See the full corporate group — holding company, subsidiaries, associates and joint ventures of Dr Zag Ambwani (India) Llp with ownership details.
MCA Filings & Documents of Dr Zag Ambwani (India) Llp
MCA Filings & Documents of Dr Zag Ambwani (India) Llp
Download official documents filed with the Ministry of Corporate Affairs — from incorporation papers to the latest annual filings.
Recent Activity on Dr Zag Ambwani (India) Llp
Frequently Asked Questions about Dr Zag Ambwani (India) Llp
Dr Zag Ambwani (India) Llp is an active limited liability partnership in the chemicals and materials sector based in Ahmedabad, Gujarat, India. It was incorporated on 19 February 2020 (6+ years old) and is registered under LLPIN AAR-9790.
The current designated partners of Dr Zag Ambwani (India) Llp are:
The primary industry of Dr Zag Ambwani (India) Llp is chemicals and materials. The LLP specifically operates in industrial chemicals. The LLP is currently active in this sector.
Dr Zag Ambwani (India) Llp can be reached at the registered office: B 120 Kubernagar, Ahmedabad, Gujarat, India – 382340.
The total obligation of contribution is ₹41 Lakh.
The LLP has its registered office at B 120 Kubernagar, Ahmedabad, Gujarat, India – 382340.